Legal Representation
Attorney
Bruce W. Longbottom
USPTO Deadlines 3 active 2 overdue
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
EXAMINER AMENDMENT
Examiner's Amendment Completed |
CNEA | Apr 22, 2025 | 76 days overdue | Low | No |
|
OPPOSITION
Notice of Publication |
NPUB | Jun 05, 2025 | 32 days overdue | Medium | Until Jul 05, 2025 |
|
ITU SOU
Notice of Allowance Mailed - SOU Required |
NOAM | Jan 01, 2026 | 178 days | High | Until Jul 01, 2026 |
Next deadline: Notice of Allowance Mailed - SOU Required
on January 01, 2026
(178 days)
Application History
13 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 1, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| May 6, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 6, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 30, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 7, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Apr 7, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 7, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Apr 7, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Apr 7, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Mar 27, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 26, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 26, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Sep 19, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
Additional Information
Design Mark
The mark consists of the blue stylized wording "ONSWIK" between two blue horizontal lines.
Color Claim
The color(s) blue is/are claimed as a feature of the mark.
Classification
International Classes
005